Nvidia Eyes Perplexity Investment at $30 Billion Valuation 
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal 
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone 
Asian Stocks Slip Ahead of Nvidia Earnings and US Inflation Data 
Trump Buys SpaceX Shares After Record IPO 
SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Trump to Host UFC Event at White House on His 80th Birthday 
Asian Currencies Slip as Dollar Rebounds on Iran Sanctions 
Bathla Group Hires Administrators as Australia Housing Slump Deepens 
SpaceX Hires Natural Gas Trader to Meet Growing Energy Needs 
FIFA Defends Balogun Ban Suspension After Trump Praise Sparks World Cup Controversy 
Tesla Raises Cybertruck Prices by $5,000 in US 
White House Defends Trump’s FIFA Peace Prize Amid Global Criticism 
FBI Faces Historic Security Challenge Ahead of 2026 FIFA World Cup 
Indian Sugar Stocks Surge on Tight Supply, Festive Demand 
ING Says Yen Is 20% Undervalued Against Dollar 
Add as a preferred source on Google
The late Lakers icon Kobe Bryant's investment for a 10 percent stake in sports drink BodyArmor for just $6 million in the company way back in 2014 has grown to $800 million.
That incredible gain surpassed by two and a half times more Bryant’s career NBA earnings of roughly $323 million in his 20 seasons playing for the Los Angeles Lakers.
When Coca-Cola acquired a minority stake in the sports drink company in 2018, Bryant's shares immediately soared to around $200 million.
Coca-Cola is reportedly close to acquiring a controlling stake in sports BodyArmor for $8 billion, which could be announced as early as Monday.
The Lakers icon keeps proving that he excelled outside the court.
After Bryant retired from the NBA in 2016, his "Dear Basketball" production brought him an Oscar for the best animated short film.
